propranolol has been researched along with Central Serous Chorioretinopathy in 3 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Central Serous Chorioretinopathy: A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy of oral propranolol, oral rifampicin, and intravitreal anti-VEGF therapies on resolution-time and visual outcome in patients with central serous chorioretinopathy (CSCR)." | 9.69 | Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy. ( Acharya, P; Javagal, AP; Narendra, N; Nayana, PK; Sandeep, K; Sreelekshmi, SR; Venugopal, KC, 2023) |
| "To describe a case of diffuse choroidal hemangioma with exudative retinal detachment treated successfully with oral propranolol." | 7.83 | DIFFUSE CHOROIDAL HEMANGIOMA MASQUERADING AS CENTRAL SEROUS CHORIORETINOPATHY TREATED WITH ORAL PROPRANOLOL. ( Dave, T; Dave, VP; Pappuru, RR; Shah, G, 2016) |
| "To compare the efficacy of oral propranolol, oral rifampicin, and intravitreal anti-VEGF therapies on resolution-time and visual outcome in patients with central serous chorioretinopathy (CSCR)." | 5.69 | Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy. ( Acharya, P; Javagal, AP; Narendra, N; Nayana, PK; Sandeep, K; Sreelekshmi, SR; Venugopal, KC, 2023) |
| "To describe a case of diffuse choroidal hemangioma with exudative retinal detachment treated successfully with oral propranolol." | 3.83 | DIFFUSE CHOROIDAL HEMANGIOMA MASQUERADING AS CENTRAL SEROUS CHORIORETINOPATHY TREATED WITH ORAL PROPRANOLOL. ( Dave, T; Dave, VP; Pappuru, RR; Shah, G, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sandeep, K | 1 |
| Venugopal, KC | 1 |
| Javagal, AP | 1 |
| Acharya, P | 1 |
| Sreelekshmi, SR | 1 |
| Narendra, N | 1 |
| Nayana, PK | 1 |
| Dave, T | 1 |
| Dave, VP | 1 |
| Shah, G | 1 |
| Pappuru, RR | 1 |
| Salehi, M | 1 |
| Wenick, AS | 1 |
| Law, HA | 1 |
| Evans, JR | 1 |
| Gehlbach, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective Non-inferiority Study of the Use of Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous Chorioretinopathy[NCT02735213] | Phase 2/Phase 3 | 88 participants (Anticipated) | Interventional | 2016-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for propranolol and Central Serous Chorioretinopathy
| Article | Year |
|---|---|
Interventions for central serous chorioretinopathy: a network meta-analysis.
Topics: Carbonic Anhydrase Inhibitors; Central Serous Chorioretinopathy; Helicobacter Infections; Helicobact | 2015 |
1 trial available for propranolol and Central Serous Chorioretinopathy
| Article | Year |
|---|---|
Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Humans; Intravitreal Injections; Propranolol; Rifampin; Tomography | 2023 |
1 other study available for propranolol and Central Serous Chorioretinopathy
| Article | Year |
|---|---|
DIFFUSE CHOROIDAL HEMANGIOMA MASQUERADING AS CENTRAL SEROUS CHORIORETINOPATHY TREATED WITH ORAL PROPRANOLOL.
Topics: Adolescent; Adrenergic beta-Antagonists; Central Serous Chorioretinopathy; Choroid Neoplasms; Diagno | 2016 |